Salmadax 250 is a combination inhaler containing Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg, used to manage asthma and chronic obstructive pulmonary disease (COPD). Fluticasone Propionate is a corticosteroid that reduces inflammation in the airways, helping to prevent asthma attacks and manage COPD symptoms. Salmeterol Xinafoate is a long-acting beta-agonist (LABA) that relaxes the muscles in the airways, improving airflow and easing breathing. Together, these medications provide both long-term control and quick relief from symptoms, improving lung function and reducing flare-ups in asthma and COPD.
Reviews
There are no reviews yet.